These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

863 related items for PubMed ID: 14755775

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [Abstract] [Full Text] [Related]

  • 3. Liver transplantation in the MELD era: a single-center experience.
    Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V.
    Dig Dis Sci; 2006 Jun; 51(6):1070-8. PubMed ID: 16865573
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
    Yao FY, Bass NM, Ascher NL, Roberts JP.
    Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [Abstract] [Full Text] [Related]

  • 6. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.
    Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, Wachs M, Bak T, Kam I, Everson GT.
    Liver Transpl; 2004 Jan; 10(1):42-8. PubMed ID: 14755776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL, Kulkarni S, Harper A, Millis JM, Cronin DC.
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [Abstract] [Full Text] [Related]

  • 9. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K, Feng S.
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [Abstract] [Full Text] [Related]

  • 10. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.
    Ravaioli M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Zanello M, Ballardini G, Varotti G, Vetrone G, Tuci F, Lauro A, Ramacciato G, Pinna AD.
    Transplantation; 2006 Feb 27; 81(4):525-30. PubMed ID: 16495798
    [Abstract] [Full Text] [Related]

  • 11. Results of the first year of the new liver allocation plan.
    Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R, United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee.
    Liver Transpl; 2004 Jan 27; 10(1):7-15. PubMed ID: 14755772
    [Abstract] [Full Text] [Related]

  • 12. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
    Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP.
    Liver Transpl; 2003 Jul 27; 9(7):684-92. PubMed ID: 12827553
    [Abstract] [Full Text] [Related]

  • 13. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    Liver Transpl; 2005 Jun 27; 11(6):621-6. PubMed ID: 15915491
    [Abstract] [Full Text] [Related]

  • 14. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May 27; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 15. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F, Coria SA, Boni R, Pereira LA.
    Transplant Proc; 2009 May 27; 41(1):226-8. PubMed ID: 19249520
    [Abstract] [Full Text] [Related]

  • 16. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar 27; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 17. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T.
    Liver Transpl; 2012 Apr 27; 18(4):423-33. PubMed ID: 22250078
    [Abstract] [Full Text] [Related]

  • 18. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, Satwah S, Shukla R, Buell J.
    Liver Transpl; 2006 Oct 27; 12(10):1519-22. PubMed ID: 17004260
    [Abstract] [Full Text] [Related]

  • 19. Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI, Huang YH, Su CW, Lin HC, Chiang JH, Chiou YY, Huo SC, Lee PC, Lee SD.
    Clin Transplant; 2008 Oct 27; 22(4):469-75. PubMed ID: 18318736
    [Abstract] [Full Text] [Related]

  • 20. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL.
    Liver Transpl; 2009 Jul 27; 15(7):754-62. PubMed ID: 19562709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.